This study is in progress, not accepting new patients
A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Marina Del Rey, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Seres Therapeutics, Inc.
- Links
- Sign up for this study
- ID
- NCT04995653
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- About 60 people participating
- Last Updated